Skip to content
Get the Balanced News app for a better experience!
The Balanced News Logo
Analytics
The Balanced News Logo

Stay Balanced, Stay Informed

Menu
  • Browse News
  • Underreported Stories
  • Curated Feeds
  • Insights
  • Analytics
  • Our Writers
  • About Us
  • Download App
Learn
  • How It Works
  • Bias Detection
  • Lens Score
  • Source Bias Checker
  • Accountability
  • Custom Feeds
Newsroom
  • Writers & Analysts
  • About TBN
  • Editorial Standards
  • Corrections Policy
  • Our Partners
  • Insights
Socials
  • Youtube
  • Instagram
  • X
  • Facebook
News Categories
  • Trending
  • Politics
  • Sports
  • Business
  • Tech
  • Entertainment
  • Health
  • Science
  • Crime
  • Lifestyle
  • National
  • International
  • Good News
  • Crypto

Get Our App

Available for iOS and Android


LensFeedsInsightsAnalyticsTrendingGood NewsSportsPoliticsBusinessCrimeTechEntertainmentHealthNationalInternational

© 2026 The Balanced News. All rights reserved.

About UsEditorial StandardsCorrectionsHelp & SupportPrivacy PolicyTerms & Conditions
Jubilant Generics Receives Rs 105.5 Crore GST Show-Cause Notice from Uttarakhand Authority

Categories

Categories

Related Coverage

Select a news story to see related coverage from other media outlets.

Related Coverage

Select a news story to see related coverage from other media outlets.

  1. Home
  2. /
  3. Business

Jubilant Generics Receives Rs 105.5 Crore GST Show-Cause Notice from Uttarakhand Authority

Analysed 28 Aug 2026·2 sources analysed·Uttarakhand, India·Business
Jubilant Generics Receives Rs 105.5 Crore GST Show-Cause Notice from Uttarakhand AuthorityPreviousNext

Jubilant Generics Ltd, a subsidiary of Jubilant Pharmova Ltd, has received a show-cause notice from the Uttarakhand GST authority demanding Rs 105.5 crore, including a penalty, for allegedly violating rules by simultaneously availing IGST refunds and benefits under the Advance Authorisation Scheme during fiscal years 2020-21 and 2021-22. The company disputes the notice, calling it legally incorrect and plans to file a detailed reply. Jubilant Pharmova expects no financial or operational impact from this notice.

Sentiment
49%
TBN's observations

First-hand measurement across 2 sources

We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (49/100). Lens Score 43/100.

Outlets measured: economictimes, news18. See how each one headlined and framed the same story in the source comparison below.

AI analysis of 2 sources · Published under editorial oversight by The Balanced News
Analysed 28 Aug 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Sentiment — Neutral (49/100)

Sentiment was consistent across outlets (48–50/100), indicating broadly factual reporting rather than editorialising.

Coverage timeline

news18 broke this story on 28 Aug, 09:16 am. Other outlets followed.

28 Aug, 09:16 am2 sources · 45 min28 Aug, 10:01 am
  1. 1
AI analysis by the TBN Bias Engine · beat methodology byMrunal Wange· Business & Economy Editor· editorial standards byOjas Kale
← Previous
Copper and Zinc Futures Rise Slightly; Aluminium Prices Dip Amid Global Trends
Next →
Global Oil Market Pressures Amid Middle East Tensions and Economic Uncertainties
news1828 Aug, 09:16 am
Jubilant Generics receives show-cause notice demanding over Rs 105 cr
  • 2
    economictimes28 Aug, 10:01 am
    Jubilant Generics receives show-cause notice demanding over Rs 105 cr
  • Who's involved

    Institutions and figures named across source coverage.

    Government
    Uttarakhand Goods and Services Tax AuthorityCentral Goods and Services Tax Division, Roorkee
    Corporate
    Jubilant Pharmova LimitedJubilant Generics Limited

    Story context

    Category
    Business
    Location
    Uttarakhand, India
    Sources analysed
    2
    Last analysed
    28 Aug 2026
    Key entities
    Generic programmingIndian rupeeCroreUttarakhandGoods and Services Tax (India)New DelhiFiscal yearRoorkeeBasketball Africa LeaguePress Trust of IndiaBioconBiosimilar